Artificial intelligence could revolutionize ARDS diagnosis and treatment

NCT ID NCT07328997

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested an artificial intelligence model that analyzes chest CT scans to help diagnose and manage Acute Respiratory Distress Syndrome (ARDS). Researchers used data from 400 ICU patients to train the AI to classify ARDS severity, recommend treatments, and predict 28-day survival. The goal is to give doctors a faster, more accurate tool to guide critical care decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CT scan
What this could lead to
If successful, this AI model could help doctors more accurately diagnose ARDS severity and choose the right treatments faster, potentially improving patient outcomes.
What could go wrong
This is a completed study using existing data, so the model's real-world performance in new patients is not yet proven. The AI may not work as well outside the study's specific hospital setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AI (ARTIFICIAL INTELLIGENCE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of critical care medicine, Zhongshan Hospital, Fudan University

    Shanghai, Fengling Rd, 200032, P. R., China

More trials for these conditions

Other studies related to the condition(s) this trial covers.